View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Noble Life Sciences
16 October 2020

In Vivo Pharmacology and PK/PD Testing of Novel Therapeutics Webinar

Noble Life Sciences is pleased to announce that it will be hosting In Vivo Pharmacology and PK/PD Testing of Novel Therapeutics Webinar on 28 October at 1pm ET, in partnership with NorthEast BioLab.

The need for expedited drug development and efficient capital allocation has placed a justified emphasis on early in vivo testing for pharmacology and disease modulation. In this webinar, our speakers would share actionable insights from our 100+ years of collective experience managing drug discovery, pharmacokinetics (PK), and biomarker testing studies.

To register, please visit our website or fill out the enquiry form attached to this page.

Diabetes is confirmed by both an absence of insulin and increase in blood glucose levels.
Skin serves as a barrier between the external environment and the underlying tissues. When the integrity of the skin is disrupted this barrier is compromised.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena